PI Industries Limited — Investor Meet, 18-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

PI Industries reported Q1 FY27 revenue of **Rs. 1,702.3 Cr**, with EBITDA at **Rs. 369.3 Cr** (22% margin) and 57% gross margin. Domestic agri volumes grew 12%, significantly boosted by 50% growth in biologicals. Exports faced headwinds, but management maintains a positive mid-to-long term outlook. The order book is stable at **$1.2 billion**.

Strategic investments in pharma and global biologicals are ongoing, impacting current subsidiary profitability but laying foundations for future growth. Q1 capex stood at **Rs. 250-260 Cr**. PI anticipates FY27 to be better than FY26, driven by export recovery, its upcoming NCE (Pioxaniliprole) launch, and new business scale-up.